NON-CLINICAL SAFETY ASSESSMENT OF GENE THERAPY (PCCA, MMAB, DOK7 AND COLQ) TO SUPPORT PLATFORM GENE THERAPY FOR CONGENITAL MYASTHENIC DISEASES (DOK7, COLQ) AND ACIDEMIA (PCCA, MMAB)

DELIVERY ORDER won by LOVELACE BIOMEDICAL RESEARCH INSTITUTE · work in ALBUQUERQUE, NM
$5,298,497
RecipientLOVELACE BIOMEDICAL RESEARCH INSTITUTE UEI MBT9RXJJ7428
Award ID75N95020F00001
Award amount$5,298,497
Award typeDELIVERY ORDER
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)
PSCAN11
Start dateSep 25, 2020
End dateMay 31, 2027
Place of performanceALBUQUERQUE, NM
Record updatedAug 5, 2026

View the official award record

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids